In the original announcement for this acquisition, FY17 PBT (or EBIT) was $457k. So revenue is the same byt they revised down claimed profitability in this document. That or they overstated profits initially as part of pumping up the deal at the time (help out the mates they gave cheap stock). Despite selling proprietary products and with the costs of CFDA and such being picked up by JAT (as per the GM documents, use of proceeds from the raise), margins were going backwards and being revised lower. The same proprietary/in-house products that are meant to be driving margin expansion and profits.
As I stated before yet got called out for not quoting facts and being "misleading", GF and Sunnya combined were claimed by JAT in their respective acquisition announcements to have EBIT margins of almost 10%. With most the revenues and COGS associated with these two acquired businesses, JAT's reported only gross margins of 6% in the HY report. This is a huge disconnect in stated and realised profitability which includes the growing contribution from "high margin" in-house products from Sunnya.
Poor governance and questionable DD by JAT who are buying low quality businesses to chase a hot theme.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
In the original announcement for this acquisition, FY17 PBT (or...
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.5¢ |
Change
-0.025(5.81%) |
Mkt cap ! $58.28M |
Open | High | Low | Value | Volume |
42.5¢ | 42.5¢ | 40.5¢ | $35.50K | 84.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6060 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 173772 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1801171 | 0.056 |
17 | 2403917 | 0.055 |
3 | 190000 | 0.054 |
2 | 220000 | 0.053 |
1 | 50000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 95645 | 1 |
0.058 | 109100 | 2 |
0.059 | 626122 | 3 |
0.060 | 600000 | 3 |
0.061 | 371000 | 4 |
Last trade - 15.29pm 25/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online